Objective: To test whether varicella zoster virus (VZV) infection of human brain vascular cells and of lung fibroblasts directly increases proinflammatory cytokine levels, consistent with VZV as a causative agent in intracerebral VZV vasculopathy and giant-cell arteritis (GCA).
Varicella zoster virus (VZV) vasculopathy is due to productive virus infection of intracerebral arteries leading to stroke or aneurysm, 1, 2 as supported by the presence of viral antigen, DNA, and herpesvirus particles in affected cerebral arteries of a patient with multiple infarcts 3, 4 and by the presence of VZV antigen in a basilar artery aneurysm from a patient who died of cardiac arrest and subarachnoid hemorrhage 2 months after occipital distribution zoster. 5 Recent studies have expanded the spectrum of VZV vasculopathy to extracranial arteries. Indeed, VZV antigen was detected in 73/107 (70%) of temporal arteries from patients with giant-cell arteritis (GCA) 6 ; in many of these arteries, VZV DNA and herpesvirus particles were also found. 7 Analysis of cerebral and temporal arteries from patients with VZV vasculopathy has revealed loss of medial smooth muscle cells, a hyperplastic intima composed of cells expressing a-smooth muscle actin, and disruption of the internal elastic lamina. 8 A striking and consistent feature of VZV vasculopathy was arterial inflammation, consisting mostly of CD4 1 and CD8 1 T cells, as well as CD68 1 macrophages; neutrophils were abundant in the arterial adventitia during early but not late infection. 9 It is important that arterial inflammation was intimately associated with an overlying thickened intima, supporting the notion that inflammatory cells secrete soluble factors (e.g., cytokines and matrix metalloproteinases) that contribute to vascular injury, remodeling, and dysfunction. 9, 10 Although the presence of VZV in conjunction with inflammation has been seen in both cerebral and temporal arteries in intracerebral VZV vasculopathy and GCA, respectively, VZV as the direct cause of arterial inflammation has not been demonstrated definitively. Thus, we tested whether VZV infection induces proinflammatory cytokines that result in arterial inflammation seen in VZV vasculopathy and GCA using 3 primary human brain vascular cell lines: (1) human brain vascular adventitial fibroblasts (HBVAFs), which are key regulators of vascular tone, function, and inflammation 11 ; (2) human perineurial cells (HPNCs), the barrier cells surrounding adventitial nerve bundles that VZV must penetrate to infect adjacent vascular cells; and (3) human brain vascular smooth muscle cells (HBVSMCs), which are considered immunoprivileged 12 but may change the phenotype in response to VZV infection and migrate to form the thickened intima. 8 Human fetal lung fibroblasts (HFLs) served as control cells in this study.
METHODS Virus and cells. Primary HBVAFs, HPNCs (Sciencell, Carlsbad, CA), and HFLs (ATCC, Manassas, VA) were seeded at 2,000 cells/cm 2 in a basal fibroblast medium with 2% fetal bovine serum (FBS), 1% fibroblast growth serum, and 1% 1003 penicillin-streptomycin (Sciencell). HBVSMCs (Sciencell) were seeded at 2,000 cells/cm 2 in a basal smooth muscle cell medium with 2% FBS, 1% smooth muscle cell growth serum, and 1% 1003 penicillin-streptomycin (Sciencell). After 24 hours, the medium was changed to basal fibroblast or basal smooth muscle cell medium with 0.1% FBS and 1% 1003 penicillin-streptomycin that was replenished every 48-72 hours for 6-7 days to establish quiescence. At day 7, quiescent HBVAFs, HPNCs, HBVSMCs, and HFLs were cocultivated with VZV-infected (30-40 pfu/mL; Ellen strain) 13, 14 or uninfected (mock-infected) HBVAFs, HPNCs, HBVSMCs, or HFLs, respectively. During the initial phase of cocultivation, a portion of cells in culture is infected; as infection progresses, virus spreads to adjacent cells. Depending on the amount of initial VZV-infected cells added and time, eventually all cells will be productively infected and die. Given the amount of virus in the inoculum used herein, at 72 hours of postinfection (hpi; height of cytopathic effect with 50-80% of cells infected), culture supernatants were collected and cells were harvested using sodium citrate 15 to optimize detection of cell surface proteins by flow cytometry.
Flow cytometry. Mock-and VZV-infected cells at 72 hpi were washed with fluorescence-activated cell sorting (FACS) buffer (phosphate-bufferedsaline containing 1% FBS) and stained with R-phycoerythrin-conjugated mouse anti-human anti-VZV-gE (Millipore, Billerica, MA) antibody using the SiteClick Antibody labeling kit (ThermoFisher, Waltham, MA) for 30 minutes at 4°C, washed with FACS buffer, and fixed with 1% paraformaldehyde. Isotype controls were used in all stainings. Cells were analyzed using a Canto-II or LSR-II flow cytometer (BD Immunocytometry Systems, San Jose, CA); .15,000 events were collected for all samples. Data were analyzed using Diva software (BD Biosciences) and FlowJo Software (Tree Star, Ashland, OR).
Multiplex electrochemiluminescence immunoassay. In the liquid phase from cell culture supernatants, levels of interleukin (IL)-1b, IL-1a, IL-2, IL-4, IL-5, IL-6, IL-7, IL-8, IL-10, IL12p70, IL-12/23p40, IL-13, IL-15, IL-16, IL-17a, interferon gamma (IFNg), tumor necrosis factor-alpha (TNF-a), tumor necrosis factor-beta (TNF-b), Eotaxin-1, Eotaxin-3, IFN-ginduced protein 10 (IP-10), monocyte chemoattractant protein 1 (MCP1), MCP4, macrophage-derived chemokine (MDC), macrophage inflammatory protein 1-alpha (MIP-1a), MIP-1b, thymus and activation-regulated chemokine (TARC), granulocyte macrophage colony-stimulating factor (GM-CSF), and vascular endothelial growth factor-A (VEGF-A) were measured using the Meso Scale Discovery (MSD) human cytokine 30-Plex kit (Rockville, MD) according to the manufacturer's instructions. Levels of transforming growth factor-b1 (TGF-b1) were measured using the human TGF-b1 kit (MSD). For each cytokine, concentrations were calculated with reference to a standard curve derived using various concentrations of the standards assayed in the same manner as the cell culture supernatants. The lower limit of detection (LLOD) was calculated as the concentration of signal that was 2.5 SD above the zero calibrator. The upper limit of detection was calculated as the concentration of signal that was 2.5 SD below the upper plateau of the standard curve. All samples were analyzed in duplicate from triplicate experiments.
Statistical analysis. Statistical analysis was performed using GraphPad Prism (GraphPad, San Diego, CA). Statistical significance was determined using the Student t test.
RESULTS Mock-infected HBVAFs secrete the highest basal level of cytokines compared with other mockinfected cells. Because adventitial fibroblasts in the outermost layer of arteries are key regulators of vascular tone, function, and inflammation, 11 basal levels of cytokines in mock-infected HBVAFs were compared with those in other mock-infected vascular cells (HPNCs and HBVSMCs) and in mock-infected HFLs commonly used to study VZV pathogenesis. As compared to mock-infected HPNCs, HBVSMCs, and HFLs ( figure 1; red , whereas TGF-b levels were significantly decreased (p , 0.05, p , 0.0005, and p , 0.005, respectively). Unique differences in HBVAF cytokine levels compared with those of HPNCs included significant increases in IL-1b (p , 0.005), IL-4 (p , 0.005), and IP-10 (p , 0.005), but a significant decrease in MCP-1 (p , 0.005). Unique differences in HBVAF cytokine levels compared with HBVSMCs showed significant increases in Eotaxin-1 (p , 0.005), IP-10 (p , 0.05), and TARC (p , 0.05), but a significant decrease in Eotaxin-3 (p , 0.05), whereas the comparison with HFL cytokine levels revealed showed significant increases in IL-1b (p , 0.005) and IL-4 (p , 0.005).
Specific cytokines significantly altered during VZV infection of HBVAFs. To monitor VZV infection, mock-and VZV-infected HBVAFs were harvested at 72 hpi and analyzed for VZV gE expression using flow cytometry. VZV-infected HBVAFs were .80% VZV gE1. Compared with the supernatant from mock-infected HBVAFs, the supernatant from VZV- 5 ). Levels of the remaining 24 analytes were either undetectable or not significantly changed.
DISCUSSION Herein, we show that VZV infection of primary HPNCs, brain vascular adventitial fibroblasts and vascular smooth muscle cells, as well as lung fibroblasts significantly upregulates multiple proinflammatory cytokines, consistent with the notion that VZV infection of vascular cells can initiate infiltration of inflammatory cells, vasculopathy, and ultimately stroke or GCA. Thus, the association of VZV and inflammation is unlikely to reflect preexisting inflammation triggering VZV reactivation; rather, VZV directly contributes to vasculitis. Several proinflammatory cytokines important in persistent inflammation and vascular remodeling, i.e., IL-8, IL-6, GM-CSF, VEGF-A, TGF-b, IL-15, and IL-16, were altered in response to VZV infection and warrant further discussion. For example, IL-8 (CXCL8), which promotes neutrophil migration to the site of infection and activation through degranulation, 16 was the only cytokine/chemokine elevated in all 4 cell lines studied. This finding is consistent with a significant increase of IL-8 levels in the CSF of patients with VZV vasculopathy compared with CSF from both patients with MS and healthy controls. 17 Moreover, robust IL-8 induction explains the neutrophil infiltration seen in VZV-infected temporal arteries 9 and the predominance of neutrophils in CSF of patients with VZV vasculopathy. 18 Finally, on discontinuation of corticosteroids in patients with GCA, serum IL-8 increases and neutrophils are activated, 19 strongly suggesting that the underlying cause of GCA, i.e., VZV, is still present to trigger arterial inflammation.
Levels of IL-6, an acute-phase proinflammatory cytokine that promotes monocyte differentiation into macrophages, 20 were increased in VZV-infected in HPNCs, HBVAFs, and HFLs, as also seen in the CSF of patients with VZV vasculopathy. 17 Indeed, macrophages represent a dominant immune infiltrate in VZV-infected arteries from patients with intracerebral VZV vasculopathy, as well as GCA. 7, 9 In HBVSMCs, the lack of a VZV-induced increase in IL-6, as well as decreases in IL-15, Eotaxin-3, IP-10, and MCP-1, adds another contributing factor to the immunoprivileged status of VSMCs. 12 Previous studies have shown that smooth muscle cells intrinsically lack essential costimulators, particularly OX40L, that activate memory T cells. 21 Our finding that the proinflammatory response to virus infection is also reduced in smooth muscle cells may contribute to the lack of medial inflammation during early VZV infection. 6 The lack of IL-6 induction in VZV-infected HBVSMCs might also represent a protective host mechanism because IL-6 induces smooth muscle cell apoptosis. 22 Two other cytokines involved in macrophage maturation and activation were differentially regulated in VZV-infected HBVAFs and HPNCs. GM-CSF levels were increased in VZV-infected HPNCs, promoting macrophage maturation in conjunction with IL-6, whereas infected HBVAFs had decreased GM-CSF, as well as decreased MCP-1, which would diminish macrophage maturation/activation during the later stages of infection compared with HPNCs. Perineurial cells are the first cells infected by VZV during reactivation, and their enhanced levels of GM-CSF and IL-6 during infection could be the initial stimulus to activate and differentiate monocytes into macrophages and retain them in the infected artery. As virus spreads to the adventitia without proper clearance, VZV-infected HBVAFs secrete less GM-CSF, potentially preventing macrophage activation and explaining the presence of macrophages in arteries up to 10 months after diagnosis of VZV vasculopathy.
The most significantly altered secretory protein observed in all 4 cell lines analyzed was VEGF-A, with levels significantly increased in VZV-infected HBVAFs, HBVSMCs, and HFLs, but significantly decreased in infected HPNCs. VEGF-A is of particular importance during VZV vasculopathy as it promotes angiogenesis, along with being a chemotactic protein for macrophages and neutrophils. 23 The role of VEGF-A in stroke is contextual and can be both beneficial and problematic. 23 The benefits of VEGF-A include neuronal protection, vasodilation, and angiogenesis; however, high levels of VEGF-A can increase blood-brain barrier (BBB) leakage to produce poststroke brain edema and severe intracranial hypertension. 24, 25 Patients with high basal levels of VEGF-A have a greater risk of stroke. [26] [27] [28] In addition, analyses in murine models of stroke have shown that prompt administration of VEGF-A increased stroke severity, whereas prompt VEGF-A blockade reduced infarct size and swelling. 24, 25 Thus, the VZV-mediated induction of VEGF-A in HBVAFs and HBVSMCs would worsen the severity of VZV vasculopathy because these infected cells in the artery would be a continual source of VEGF-A acting to disrupt the BBB, enhance intracranial hypertension, and promote macrophage/neutrophil infiltration. Note that simian varicella virus infection induced VEGF-A, along with IL-8 and IL-6, during acute infection in rhesus macaques, 29 further supporting the VZV-mediated induction of VEGF-A reported herein. Although diminished VEGF-A secretion by VZV-infected HPNCs in the artery could initially prevent these adverse effects of VEGF-A, virus is not cleared from this cellular layer during reactivation and can spread to the adventitia and smooth muscle cell layer. Diminished VEGF-A secretion by VZVinfected HPNCs might reflect the delay in neuronal/arterial protection required for viral spread and VZV vasculopathy onset.
Both VZV-infected HBVAFs and HFLs showed significantly increased secretion of TGF-b, a pleotropic cytokine that can induce migration and proliferation. 30 This increase in TGF-b mediated by VZV could enhance the migration of adventitial fibroblasts in the infected artery, promoting the vascular remodeling that is a hallmark of stroke/vasculitis. TGF-b is also an immunosuppressive cytokine that would diminish viral clearance in the infected artery and possibly explain our recent finding of VZVmediated downregulation of major histocompatibility complex-I in uninfected bystander cells. 31 Along with TGF-b, IL-16, a cytokine that activates CD4
1 T cells and can be secreted by TGF-bstimulated fibroblasts, 32 was also significantly elevated in VZV-infected HBVAFs, consistent with the infiltrate of CD4 1 T cells observed in both early and late VZV vasculopathy. Significant elevations in IL-2 secretion seen in VZV-infected HPNCs would also aid in T-cell activation. Of interest, VZV has a tropism for CD4
1 T cells, and the induction of IL-2 and IL-16 in the infected arteries could aid in the viral tropism for these cells. Both VZV-infected HBVAFs and HBVSMCs also secreted significantly less IP-10, which could inhibit viral clearance in the infected artery because IP-10 acts as a chemoattractant for activated T cells and is required for host defense against virus-induced neurologic disorders. 33 The VZV-mediated targeting of this pathway to promote viral spread and persistent inflammation during VZV vasculopathy is supported by analysis of IP-10 murine knockout models, which revealed a dramatic reduction in viral clearance and enhanced inflammation during infection of the eye with herpes simplex-1, another member of the alpha-herpesviridae subfamily, compared with wild-type mice. 34 IL-15 is a proinflammatory cytokine that activates natural killer cells and enhances memory CD8 1 T-cell responses. 35 Based on the functional properties of this cytokine, the VZV-mediated induction of IL-15 in HFLs could enhance viral clearance in the lung during primary infection. VZV-infected HBVSMCs had significantly reduced levels of secreted IL-15, which has been shown to inhibit smooth muscle cell proliferation. 36 Furthermore, blockade of IL-15 during arterial injury increased intimal thickening in mice, 37 a finding particularly relevant in VZV vasculopathy because a thickened intima and smooth muscle cell migration and differentiation into a myofibroblast phenotype are hallmarks of this disease, along with pulmonary hypertension and stroke in general. 11 Overall, our comprehensive analysis of the cytokines secreted by multiple cells in the artery and by lung fibroblasts after VZV infection shows that the virus significantly upregulates and downregulates several cytokines in various combinations distinct for each cell type. Most notable in VZV-infected vascular cells is the detection of elevated IL-8 and IL-6, which promote neutrophil and macrophage migration/activation in the infected artery, as well as the detection of elevated VEGF-A, which promotes BBB permeability and immune infiltration. Of interest, IL-6 is the major cytokine involved in GCA pathogenesis, [38] [39] [40] whereas IL-8 and VEGF-A have been found to play a major role in disease progression as well. 39 Together with a previous report that VZVinfected arteries downregulate PD-L1 to promote persistent inflammation, 31 these data demonstrate that VZV infection is sufficient to promote a proinflammatory environment within 72 hours, which may potentially lead to a persistent vasculitis, and support VZV as the causative agent in intracerebral VZV vasculopathy and GCA.
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